SERPINA1 and cardiac rhythm disease: Given previous in vitro studies demonstrated that S-75 blocked α1A- and α1B-adrenoceptors, and these receptors can contribute to the development of cardiac arrhythmias induced by catecholamines, we aimed to evaluate the compound’s antiarrhythmic activity.